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Abstract
Background: Tendon injuries occur frequently in human and equine athletes. Treatment options are limited, and
the prognosis is often poor with functionally deficient scar tissue resulting. Fetal tendon injuries in contrast are
capable of healing without forming scar tissue. Embryonic stem cells (ESCs) may provide a potential cellular
therapeutic to improve adult tendon regeneration; however, whether they can mimic the properties of fetal
tenocytes is unknown. To this end, understanding the unique expression profile of normal adult and fetal tenocytes
is crucial to allow validation of ESC-derived tenocytes as a cellular therapeutic.
Methods: Equine adult, fetal and ESC-derived tenocytes were cultured in a three-dimensional environment, with
histological, morphological and transcriptomic differences compared. Additionally, the effects on gene expression of
culturing adult and fetal tenocytes in either conventional two-dimensional monolayer culture or three-dimensional
culture were compared using RNA sequencing.
Results: No qualitative differences in three-dimensional tendon constructs generated from adult, fetal and ESCs were
found using histological and morphological analysis. However, genome-wide transcriptomic analysis using RNA
sequencing revealed that ESC-derived tenocytes’ transcriptomic profile more closely resembled fetal tenocytes as
opposed to adult tenocytes. Furthermore, this study adds to the growing evidence that monolayer cultured cells’ gene
expression profiles converge, with adult and fetal tenocytes having only 10 significantly different genes when cultured
in this manner. In contrast, when adult and fetal tenocytes were cultured in 3D, large distinctions in gene expression
between these two developmental stages were found, with 542 genes being differentially expressed.
Conclusion: The information provided in this study makes a significant contribution to the investigation into the
differences between adult reparative and fetal regenerative cells and supports the concept of using ESC-derived
tenocytes as a cellular therapy. Comparing two- and three-dimensional culture also indicates three-dimensional culture
as being a more physiologically relevant culture system for determining transcriptomic difference between the same
cell types from different developmental stages.
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Background
Exercise-induced tendon injuries occur commonly and
account for 30–50% of all sporting injuries [1]. The
Achilles tendon (AT) is particularly vulnerable to injury,
along with knee and rotator cuff tendons [2]. AT injuries
in humans have remarkable similarities with superficial
digital flexor tendon (SDFT) injuries in horses [2, 3].
Both the AT and SDFT serve not only to connect skel-
etal muscle to bone, but also provide a means of energy-
storing to facilitate high-speed locomotion, a function
for which no other animal model possesses [3]. Given
the less demanding regulatory framework for biological
treatments in animals and relative ease of access to
equine tissue, the horse is one of the most scientifically
sound animal models for studying such injuries [3].
Healing in both human and equine tendon is often
prolonged, with injuries undergoing poor natural regen-
eration and instead healing via fibrotic scar tissue forma-
tion. This fibrosis pre-disposes the tissue to high re-
injury rates of up to 67% in racehorses and 31% in hu-
man athletes [3, 4]. Fetal tendon injuries on the other
hand are capable of regenerating without scar tissue for-
mation [5] in a process which is intrinsic to the fetal ten-
don cells themselves, as fetal tendons transplanted into
an adult environment retain their regenerative capacity
[6]. This fetal regenerative response has also been ob-
served in other tissues and may be controlled at the cel-
lular level [7–13].
The remarkable healing capacity of fetal cells has
driven investigations into their use as a cellular therapy.
Fetal skin and tendon progenitor cells are already being
tested in clinical trials [14–17]. However, access to hu-
man fetal tissue is an issue when considering the use of
such treatments in clinical practice. Requirements for
parental consent and recent changes in the US federal
government’s policies on using human fetal tissue from
elective abortions [18] means that sources of fetal tissue
are limited. Furthermore, in order to obtain enough cells
for transplantation, cells must be serially passaged on tis-
sue culture plastic, which can lead to an altered cellular
phenotype due to in vitro selective pressures [19–23]. Re-
generative medicine methodologies which mimic fetal-like
regeneration are therefore required.
Adult-derived mesenchymal stromal cells (MSCs) are
being used in the veterinary field [24]. To date, various
MSC sources have been investigated, with companies
now offering “off the shelf” MSCs to be used allogenei-
cally in horses [25, 26]. Early phase clinical trials have
also been conducted in humans using autologous MSCs
for treating rotator cuff disease [27]. However, questions
regarding their efficacy remain, and the concept of how
MSCs function has changed considerably over the years
[28]. MSCs were initially thought to migrate to the in-
jury site, differentiate into functional cells and engraft
into the injured tissue. However, the survival rate of
injected MSCs is poor [29–31] and it is now hypothe-
sised that MSCs may instead work via modulation of the
inflammatory environment [32, 33].
Embryonic stem cells (ESCs) present another potential
therapeutic option as they can differentiate into deriva-
tives of all three germ layers, be propagated extensively
in culture with manual passaging whilst maintaining a
stable karyotype [34–36] and have a degree of immune
privilege [32, 37–39]. We have previously isolated and
characterised equine ESCs and demonstrated that when
injected into the injured horse tendon, they exhibit a
high survival rate, express tendon-associated markers
and do not illicit an immune response within a 90-day
study period [29, 40–42]. However, the long-term sur-
vival/rejection of these cells is unknown, and studies in
human and mouse models have indicated a high likeli-
hood of teratoma formation based on injection into
other transplantation sites [43]. To avoid this risk, strat-
egies to induce human and mouse ESCs towards the ap-
propriate lineage prior to clinical application have been
investigated [44–49].
Equine ESCs differentiate into tenocytes in vitro in re-
sponse to transforming growth factor-β3 (TGF-β3) and
three-dimensional (3D) culture [42, 50, 51]. Similarly,
human ESCs have been differentiated into tenocytes
in vitro [52, 53]. Transplantation of differentiated ESC-
derived 3D fibrin tendon gels into rat patella tendon in-
jury models has indicated that ESC-tenocytes secrete a
number of fetal tendon matrix and differentiation factors
[52], highlighting the potential role ESC-tenocytes may
play in tissue regeneration. However, to date, a full tran-
scriptional characterisation of ESC differentiated teno-
cyte progeny has not been performed. In this study,
next-generation sequencing was performed using equine
fetal, adult and ESC-tenocytes cultured in 3D allowing
for comparison of their transcriptomic profiles. 3D cul-
ture was also compared to its typical two-dimensional
(2D) counterpart to highlight the detrimental effects of
culturing cells in conventional monolayer systems.
Materials and methods
Tenocyte cell culture
Tendons were processed with the approval of the Ani-
mal Health Trust ethical review committee (AHT02_
2012) as previously described [50]. Tenocytes were iso-
lated post-mortem from healthy SDFTs of eight adult
Thoroughbred horses (2–10 years) that were euthanised
for reasons unrelated to this project, and from tendons
of seven fetuses at 271, 289, 316, 319, 320, 321 and 340
days of gestation which had undergone spontaneous
abortion. Briefly, dissected tissue was digested overnight
at 37 °C in 1 mg/ml collagenase (Sigma, Poole, Dorset,
UK) solution. Cells were expanded in Dulbecco’s
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modified Eagle’s Medium (DMEM) (Gibco, Invitrogen,
Carlsbad, CA, USA) with 10% fetal bovine serum (FBS)
(Gibco), 1% penicillin-streptomycin (P/S) (Gibco) and 2
mM L-glutamine (LQ) (Gibco). Culture conditions were
maintained at 37 °C in 5% CO2, with medium being re-
placed every 2–3 days. Once cells reached 80% confluency,
they were passaged using 0.25% trypsin/EDTA (Sigma).
Embryonic stem cell culture
Three lines of previously characterised ESCs [40, 41],
isolated from three different embryos, were used. ESCs
were maintained at 37 °C in 5% CO2 on a mitotically
inactivated mouse embryonic fibroblast layer as previ-
ously described [40, 41]. Briefly, cells were cultured in
DMEM/F12 containing 15% FBS (Gibco), 2 mM LQ,
1% non-essential amino acids, 1 mM sodium pyruvate,
0.1 mM 2-mercaptoethanol (all from Invitrogen, Ren-
frewshire, UK) and 1000 U/ml leukaemia inhibitory
factor (LIF) (Cambridge University, Biochemistry Depart-
ment, UK). ESCs were passaged mechanically every 5–7
days in the presence of 2 μM Thiazovivin (StemGent,
Cambridge, MA, USA), with medium replaced daily.
Three-dimensional cell culture and ESC differentiation
3D cell culture was conducted as previously described
[50, 54] on silicon-coated six-well plates (Sylgard 184
Silicone elastomer; Dow Corning) with pairs of 0.2-mm-
diameter minutien pins (Interfocus fine science tools)
embedded at 15 mm distances. Tenocytes were sus-
pended (4 × 105 cells/ml) in a chilled mixture of eight
parts PureCol (Bovine collagen type I; Advanced Bioma-
trix, Carlsbad, CA, USA) to 2 parts medium (pH ad-
justed from 7.2 to 7.6 with 1M sodium hydroxide), with
200 μl being pipetted around each pair of pins before
allowing to set at 37 °C for 60–90 min. Once set, 3 ml of
tenocyte medium was added to each well. For tendon
differentiation, mechanically passaged clumps of ESCs were
used to prepare three-dimensional constructs at the same
cell density and were cultured in ESC medium without LIF,
a protocol which our group has shown is sufficient to pro-
mote tenogenic differentiation in equine ESCs [50]. 3D cul-
tures were maintained for 14 days with the medium
changed every 3–4 days. ImageJ software (National Insti-
tutes of Health) was used for contraction analysis with
values displayed as a percentage of the day 0 value.
RNA isolation
Three lines of fetal, adult and ESC-tenocytes cultured in
3D and adult and fetal tenocytes cultured in 2D were
used in the RNA-sequencing experiments. The 2D sam-
ples, although processed in parallel, are available through
NCBI GEO, (https://www.ncbi.nlm.nih.gov/geo/) under
accession number GSE132358 [39]. Tenocytes were used
between passages (P) 3 and P8. Differentiated ESCs were
used between P12 and P22. Quantitative PCR (qPCR)
validation of the RNA-sequencing data was conducted
using eight lines of adult tenocytes and seven lines of
fetal tenocytes. RNA was harvested in 1 ml Tri-reagent
(Sigma) per six to nine gel constructs for 3D-cultured
cells or per 10 cm2 plate for 2D-cultured cells. RNA was
extracted and purified using a RNeasy mini kit (Qiagen,
Manchester, UK). The Ambion DNA-free kit was used
to remove any contaminating DNA (Life Technologies,
Paisley, UK). RNA concentration was measured using a
Nanodrop (ThermoFisher, Loughborough, UK). RNA in-
tegrity was confirmed on an Agilent 2200 Tapestation
by an external provider (Cambridge Genomics, Cam-
bridge, UK), with RNA Integrity Number (RIN/RINe)
values of 9.1–10 obtained.
RNA sequencing
mRNA library prep and sequencing was performed by ex-
ternal providers (Edinburgh Genomics, Edinburgh, UK and
Otogenetics, Atlanta, USA) using a TruSeq stranded
mRNA kit (Illumina, Cambridge, UK) or Clonetech Smart
cDNA kit (Clonetech laboratories, CA, USA) and the Nova-
Seq6000 (Illumina) and Illumina HiSeq2500, respectively.
Twenty million reads of approximately 100 base pair
paired-end were generated per sample. FASTQC and
FASTQ Screen (Babraham Bioinformatics, Cambridge, UK)
were used on the FASTQ files to ensure quality. Reads were
aligned to the Ensemble version v96 EquCab 3.0 transcrip-
tome using the pseudoaligner Salmon [55] with GC-bias
correction (-gcBias) in Quasi-mapping based mode. Txim-
port [56] was used to import the gene-level abundance data
into R (v.3.5.2) and R/Bioconductor DSeq2 (v.1.22.2) used
to conduct differential expression analysis as described in
Love et al. [57], with batch correction applied. Genes with
Log2FC of ± 2 and adjusted p value (p-adj) of < 0.01 were
considered differentially expressed (DE). Gene Ontology
(GO) analysis was performed using Panther (http://www.
pantherdb.org/), with a false discovery rate (FDR) of < 0.05
being defined as significantly enriched. Pathway analysis
was performed using Gene Analytics from the LifeMap’s
GeneCards Suite (http://geneanalytics.genecards.org) with
entity scores of > 13 being classed as highly enriched.
cDNA synthesis and quantitative PCR
One microgram of RNA was reverse transcribed using the
SensiFAST cDNA Synthesis Kit (Bioline, London, UK).
Reactions lacking the reverse transcriptase were carried
out to ensure no genomic DNA contamination. Equine
gene-specific primers were designed using NCBI
Primer-Blast (https://www.ncbi.nlm.nih.gov/tools/pri-
mer-blast/) (Additional file 1: Table S1). qPCR was
carried out on the Bio-Rad C1000 Touch Thermal Cy-
cler (Bio-Rad), using supermix containing SYBR Green
(Bioline). qPCR cycling parameters were 95 °C for 10
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min, followed by 45 cycles of 95 °C for 15 s, 60 °C for
15 s and 72 °C for 15 s. Reactions were quantified rela-
tive to 18s rRNA housekeeping gene [58], whose stability
was determined using RefFinder [59] (data not shown). The
relative gene expression was calculated using: 1/2ΔΔCT [60].
Statistical significance in mean gene expression was deter-
mined using a Student’s t test.
Serial passaging effects
Three lines of adult tenocytes were isolated and passaged
ten times in 2D culture, with RNA extracted at every pas-
sage to measure COL1A2, SCX, THBS4 and TNMD gene
expression via qPCR. Statistical significance was tested
using linear regression analysis using R (v.3.5.2).
Histology and immunocytochemistry on sectioned 3D
constructs
Three lines of adult, fetal and ESC-tenocyte 3D constructs
were embedded in OCT compound (VWR) and snap-
frozen in liquid nitrogen-cooled isopentane. Eleven-
micrometre-thick, longitudinal sections were cut using a
cryostat, fixed for 10min in 100% acetone and stored at −
20 °C. Sections were used for haematoxylin and eosin
(H&E) and Picro Sirius Red staining (ab150681, Abcam,
Cambridge, UK).
For immunocytochemistry, sections were blocked in
2.5% normal horse serum (Vector Laboratories, Peter-
borough, UK) for 20 min before incubating with primary
antibodies overnight at 4 °C, with subsequent detection
using fluorescently labelled secondary antibody. Anti-
bodies were used at optimised concentrations in 2.5%
normal horse serum (Vector Laboratories) (Additional
file 1: Table S2). Colorimetric images were captured
using the Olympus IMT2-SFR inverted microscope, with
polarising filters added for visualising Picro Sirius Red
staining (Abcam). Fluorescence images were captured
using the Zeiss Axioplan 2 imaging suite. Subsequent
images were analysed qualitatively.
Immunocytochemistry on 2D coverslips
Three lines of adult and fetal tenocytes were cultured on
gelatin-coated (Sigma) coverslips in 1% serum medium
and 24 h later incubated with or without the addition of 5
ng/ul TGFβ-3 (Peprotech, London, UK) for 30min before
fixing for 20min in 3% paraformaldehyde. Cells were per-
meabilised in 0.1% triton-X-100 for 1 h. Primary and sec-
ondary antibody incubations were done as above for 3D-
cultured cells (Additional file 1: Table S2).
Migration assay
Four biological lines of adult and fetal tenocytes were
treated with 10 μg/ml of mitomycin C (Sigma) at 37 °C
for 2 h to inhibit cell proliferation prior to culture in 1%
serum medium. Following mitomycin C treatment,
3.82 × 104 cells were plated into each well of a 24-well
Transwell® plate, pore diameter 8 μm (Corning Incorpo-
rated, NY, USA). Growth factors (5 ng/ul TGFβ-3, 10
ng/ml bFGF, 5 ng/ml PDGF, 10 ng/ml and 5 ng/ml, re-
spectively, bFGF + PDGF, 100 ng/ml IGF-1 (Peprotech))
were added to the lower well for 24 h of culture. The in-
serts were fixed for 20 min at room temperature in 3%
paraformaldehyde and washed 3 times in PBS and the
cells on the upper membrane were removed with a cell
scraper (ThermoFisher). The remaining cells (on the
lower side of the membrane) were stained for 10 min in
1% crystal violet solution (Sigma), and five images at × 4
magnification and nine images at × 10 magnification
were taken on an EVOS XL Core Cell Imaging System
(ThermoFisher). Image analysis was performed using
ImageJ software with the average cell coverage being cal-
culated and statistically significant effects being deter-
mined via a Student’s t test.
Results
Serial passaging of equine tendon cell alters gene
expression
The effect of serial passaging on the expression of four
tendon-associated genes, COL1A2, SCX, THBS4 and
TNMD, in equine tenocytes was measured in this study.
COL1A2 expression was variable with passaging, with a
significant difference from P0 only being observed at P6
and P7 (p value = 0.0256 and 0.0027, respectively) (Add-
itional file 2: Figure S1A). SCX expression at P0 was sig-
nificantly higher than from P4 through to P10 (p values
all < 0.05) (Additional file 2: Figure S1B). However, SCX
levels did not change beyond P4 with further passaging.
THBS4 at P0 was significantly higher than from P1
through to P10 (p values all < 0.05) (Additional file 2: Fig-
ure S1C). However, THBS4 levels did not change beyond
P4 with further passaging. TNMD at P0 was significantly
higher than at P1 through to P10 (p value = 0.009). How-
ever, TNMD expression did not change beyond P1 with
further passaging (Additional file 2: Figure S1D).
Cellular characterisation of adult, fetal and embryonic
tenocytes cultured in 3D reveals no quantitative or
qualitative differences
We have previously demonstrated that equine ESCs can
differentiate into tenocytes in both 2D and 3D culture,
showing increased differentiation in 3D [50]. 3D con-
structs cultured for 14 days showed no significant differ-
ences in the degree of contraction between cell types
(data not shown). Collagen fibre alignment or cell distri-
bution between cell types was also not qualitatively dif-
ferent (Fig. 1a and Additional file 2: Figure S2). Picro
Sirius Red staining similarly indicated that the relative
staining of type I collagen to type III collagen was not
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qualitatively different between cell types (Fig. 1a and
Additional file 2: Figure S2).
Embryonic tenocytes cultured in 3D are transcriptomically
more similar to fetal than adult tenocytes but represent a
unique population
Gene expression profiles obtained by RNA sequencing
of the entire equine genome yielded 6190 DE genes in
total across the three 3D-cultured cell type comparisons
(Log2FC of ± 2 and p-adj of < 0.01) (Fig. 1c). Principle
component analysis (PCA) showed clear segregation of
the three cell types, with the greatest variance on PC1
separating the ESC-tenocytes from the adult and fetal
tenocytes (Fig. 1b). Of the 21,689 mapped genes, 542
genes were DE between the adult and fetal tenocytes,
2940 genes were DE between the adult and ESC-
tenocytes and 2708 genes were DE between the fetal and
the ESC-tenocytes. Gene-level summaries can be found
in Additional file 3.
To further identify the cells as being tenocytes, a panel
of 28 musculoskeletal-associated genes identified from
the current literature [61–65] were examined. ESC-
tenocytes expressed all tendon-associated genes, how-
ever, at lower levels compared to adult and fetal teno-
cytes (Fig. 1d). Of the eight cartilage genes, only COMP
and THBS3 showed significant differences between the
Fig. 1 Morphological and transcriptomic comparison of adult, fetal and ESC-tenocytes. a Haematoxylin and eosin (H&E) and Picro Sirius Red
staining of adult, fetal and ESC-derived 3D constructs. All cell types show similar collagen fibre alignment and collagen content within the
constructs after 14 days of culture. Scale bar for H&E = 0.5 mm. Scale bar for Picro Sirius Red = 250 μm. Images shown are representative of three
biological repeats. Under light microscopy, all collagen fibres are red following Picro Sirius Red staining, under polarised microscopy collagen type
I fibres have yellow-orange birefringence and collagen type III fibres have green birefringence. b Principle component analysis of gene expression
data profiling three biological lines of 3D cultured adult, fetal and ESC-tenocytes. c Matrix of up (green) and down (red) regulated genes for each
of the pairwise comparisons. Values represent the number of up- and downregulated genes based on an adjusted p value of < 0.01 and a
Log2FC of ± 2. d Boxplots of gene expression of cartilage, tendon and bone markers in adult (teal), fetal (orange) and ESC-tenocytes (yellow). Y-
axis shows the gene expression in terms of the log normalised counts. Significant differences are depicted by an asterisk (*) with black asterisks
representing a significant difference between the ESC-tenocytes and both the adult and fetal tenocytes, blue asterisks representing a significant
difference between the ESC-tenocytes and adult tenocytes only, green asterisks representing a significant difference between the adult tenocytes
and both the ESC and fetal tenocytes and purple asterisks representing a significant difference between all three groups
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cell types, with both markers having the lowest expres-
sion in ESC-tenocytes. The bone genes CD36, SNCG
and SPP1 were expressed significantly more in the ESC-
tenocytes, but RUNX2 was expressed at a significantly
lower level in the ESC-tenocytes.
To better understand the differences between fetal and
adult tenocytes, a heatmap was constructed of the top
30 DE genes. This resulted in dendrogram clustering of
the fetal tenocytes with the ESC-tenocytes, with 21 out
of the 30 genes showing a more similar expression pat-
tern than with adult tenocytes (Fig. 2a). Cluster 1 high-
lights six genes which are highly upregulated in adult
tenocytes, whereas clusters 4 and 5 show 15 genes
which are highly downregulated in adult tenocytes.
Two clusters, 2 and 3, consisting of 9 genes in total,
show a more closely related expression between ESC-
tenocytes and adult tenocytes. Heatmaps of the top
100, 200 and 500 genes were also constructed and re-
sulted in similar dendrogram clustering of the fetal
tenocytes with the ESC-tenocytes (Additional file 2:
Figure S3).
Comparison of overrepresented gene ontologies and
pathways in adult, fetal and embryonic tenocytes
cultured in 3D
Gene ontology (GO) analysis was performed on the
genes identified as being DE between the three different
groups. The top 10 over-enriched terms are listed in
Fig. 2b. Next to the more common terms (e.g. regulation
of cell communication, signal transduction, and cellular
processes), DE genes between adult and fetal tenocytes
were assigned to processes involving the inflammatory
response, cellular migration and motility. Comparing
ESC-tenocytes to adult and fetal tenocytes revealed
pathways involved in organism processes, develop-
ment and biological and cellular adhesions as being
significantly overrepresented (Fig. 2b). DE genes were
then overlaid into GeneAnalytics Pathway Analysis.
ERK, PAK, Akt and PI3K-Akt signalling were differ-
entially regulated among all three groups, as was
extracellular matrix (ECM) degradation (Additional
file 1: Table S3). In corroboration with the GO ana-
lysis, cytokine signalling in the immune system was
found to be differentially regulated in adult and fetal
tenocytes (Additional file 1: Table S3).
Validation of 3D RNA-seq results by qPCR and
immunofluorescence is highly corroborative
To validate the biological significance of the RNA-seq
data, several DE genes were investigated at either the
RNA level, protein level or both (Fig. 3a, b). For qPCR
validation, the original samples sequenced were used
alongside an additional cohort of adult (total n = 8) and
fetal tenocytes (total n = 7). Of the eleven genes tested,
there was a 79% corroboration to that of the RNA-seq
data (Fig. 3a). Validation via immunocytochemistry,
Fig. 2 Heatmap of top DE genes and GO terms comparing adult, fetal and ESC-tenocytes. a Differential gene expression analysis for top 30 genes
DE in adult and fetal tenocytes. Dendrograms are based on Pearson’s correlation, with red and blue colours representing up- and downregulated
genes, respectively. Samples with intermediate expression are represented in yellow. Groups are visualised in columns, with the coloured bar
above the heatmap indicating the grouping variable. Genes are represented in individual rows, with patterns of up- and downregulated genes
being classified into 5 clusters. b Summary of the top 10 significantly enriched gene ontology (GO) biological process terms for each pairwise
comparison of DE genes in adult, fetal and ESC-derived tenocytes. Go terms are arranged alphabetically to allow easier comparison between
each group
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although not quantitative, showed a high consensus to
that of the sequencing data, with ACTA1, IGF1, LOXL4,
SCX and THBS4 having visibly higher protein expres-
sion in the adult tenocytes compared to the fetal and
ESC-tenocytes as predicted (Fig. 3b). Protein expression
of PDGFB and RUNX2 did not corroborate with sequen-
cing data, and no visible differences were observed be-
tween the three groups (Fig. 3b). BMP7 expression was
expected to be absent from adult and ESC-tenocytes
based on the RNA-seq data; however, protein was de-
tectable in the ESC-tenocytes and adult tenocytes, al-
though at a lower level (Fig. 3b).
Adult and fetal tenocytes respond differently in their
migratory abilities upon addition of growth factors
As genes involved in cell migration were DE between
adult and fetal tenocytes, cell migration assays were per-
formed. Growth factors bFGF and PDGF either alone or
in combination had no significant effect on adult or fetal
tenocytes (Fig. 4b). IGF-1 resulted in marked morpho-
logical changes (Fig. 4a) and appeared to show an in-
creased migration rate, but this was not significant (p
value 0.052 and 0.058, respectively, for adult and fetal
tenocytes) (Fig. 4b). However, TGF-β3 significantly
inhibited cell migration in fetal tenocytes but had no
Fig. 3 Validation of RNA-sequencing results. a Comparison of DE genes using RNA-seq and qPCR results using a log2FC cut-off ± 2. Significance
threshold for RNA-seq p-adj values < 0.01 as routinely used. Significance threshold for qPCR p-value < 0.05 as routinely used. Red shaded boxes
indicate no significant difference. Yellow shaded boxes represent a significant p-adj value; however, they do not meet the log2FC cut-off. Green
shaded boxes indicate there is a significant difference based on both p-adj/p value and log2FC. NA values present typically arise due to count
outliers as detected by Cook’s distance. b Immunocytochemistry comparison of the corresponding proteins for 12 significantly DE genes. Images
represent longitudinal sections of 3D adult, fetal and ESC seeded constructs following 14 days of culture (n = 3 for each cell type). RNA-
sequencing log2FC are listed in the adjoining tables with green text indicating significance based on p-adj value of < 0.01 and red text indicating
no significant difference. Scale bar = 40 μm. DAPI staining of the nuclei is shown in blue
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Fig. 4 Comparison of migratory properties in response to growth factors. a Representative image of crystal violet staining of adult tenocytes with
and without the addition of 100 ng/ml IGF-1 grown in 1% serum tenocyte medium. Scale bar = 500 μm. Images shown are representative of
three biological repeats of both adult and fetal tenocytes. b Log2FC in cell migration in adult and fetal tenocytes following 24-h exposure to
growth factors compared to the control. Error bars represent the s.e.m. of three biological replicates. *p < 0.05 based on Student’s t test. c Log2FC
in gene expression in adult and fetal tenocytes following exposure to TGF-β3 compared to the non-exposed control. Error bars represent the
s.e.m. of three biological replicates. Student’s t test *p < 0.05. d Boxplots showing the log normalised expression counts of TGF-β receptors 1 and
2 and SMAD2 and SMAD3 in adult and fetal tenocytes cultured in both 2D and 3D. Statistical significance based on an adjusted p value of < 0.01
and a Log2FC of ± 2 (*). e Boxplots showing the log normalised expression counts of TGF-β receptors 1 and 2 and SMAD2 and SMAD3 in adult,
fetal and ESC-tenocytes cultured in 3D. Statistical significance based on an adjusted p value of < 0.01 and a Log2FC of ± 2 (*). f
Immunofluorescence staining of TGF-β receptors 1 and 2 and SMAD2/3 in adult and fetal tenocytes cultured in 2D. SMAD2/3 is translocated to the
nucleus of both adult and fetal tenocytes following 30 min of TGF-β3 exposure. DAPI staining of the nucleus is shown in blue. Scale bar = 40 μm.
Images shown are representative of three biological repeats
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effect on adult tenocytes (p values 3.9 × 10− 6 and 0.69,
respectively) (Fig. 4b). To further explore this difference
in migration in response to TGF-β3, qPCR was used to
test several genes involved in cellular migration; how-
ever, no significant differences were found between the
adult and fetal cells (Fig. 4c).
TGF-β receptor expression in fetal, adult and ESC-
tenocytes was also compared. TGF-β receptor 1 (TGF-βRI)
was not DE in adult and fetal tenocytes cultured in 2D or
3D; however, ESC-tenocytes in 3D expressed significantly
less TGF-βRI than adult tenocytes (Log2FC 2.064, p-adj
3.41e−09) (Fig. 4d, e). Similarly, no differences were ob-
served in TGF-βR2 expression between adult and fetal
tenocytes in 2D or 3D culture; however, ESC-tenocytes in
3D expressed significantly less TGF-βRII than both adult
tenocytes (Log2FC 5.385, p-adj 6.29e−03) and fetal teno-
cytes (Log2FC 5.083, p-adj 0.0014) (Fig. 4d, e). As mRNA
does not always corroborate with protein expression, as de-
scribed in Fig. 3b, immunofluorescence staining on 2D-
cultured cells was performed to confirm and compare ex-
pression of both receptors in adult and fetal tenocytes
(Fig. 4f). SMAD2/3, which translocates in response to TGF-
β3 signalling, has similar gene expression between fetal,
adult and ESC-tenocytes cultured in both 2D and 3D
(Fig. 4f). Immunofluorescence staining showed clear trans-
location of SMAD2/3 into the nucleus in the presence of
TGF-β3 in both adult and fetal tenocytes (Fig. 4f). As 3D
culture does not allow for clear visualisation of cell nuclei,
receptor staining and subsequent translocation assays were
only performed in 2D-cultured cells.
2D monolayer culture results in convergence in the
expression profiles of adult and fetal tenocytes
Hierarchical clustering and PCA were conducted on adult
and fetal tenocytes cultured in either 2D or 3D (Fig. 5a, b).
Analysis revealed a convergence of expression profiles in
2D, with only 10 genes being DE. This is in comparison to
542 DE genes in 3D. When comparing adult tenocytes cul-
tured in either 2D or 3D culture, 502 genes were DE,
whereas in fetal tenocytes cultured in either 2D or 3D cul-
ture, 851 genes were DE. Of these, only 183 genes were
common between adult 2D versus 3D culture and fetal 2D
versus 3D culture (Fig. 5c). GO analysis of these 183 genes
revealed cell adhesion (GO:0007155) and cell surface recep-
tor signalling (GO:0007166) as key overrepresented bio-
logical processes (Additional file 1: Table S4). Degradation
of the ECM was a common pathway which was differen-
tially regulated in both adult and fetal tenocytes as a result
of 2D or 3D culture, with differences in collagens, matrix
metalloproteinases and integrins (Additional file 1: Table
S5). Muscle contraction was a predominant pathway which
was found to be enriched in monolayer cultures, whereas
TGF-β, ERK, PAK and Akt signalling was enriched in 3D-
cultured cells.
Fig. 5 Comparison of gene expression changes upon 2D and 3D culturing of equine tenocytes. Comparison of RNA transcriptome profile
between three biological lines of fetal and adult tenocytes cultured in either a 2D or 3D. a Euclidean sample-to-sample distance matrix with
hierarchical clustering using VST transformed data. b Principle component analysis of gene expression data profiling three biological lines of 3D
versus 2D cultured adult and fetal tenocytes. c Quantitative VENN diagram showing overlap of DE genes in the adult 3D vs 2D culture
comparison (teal) and fetal 3D vs 2D culture comparison (orange). Top 4 upregulated genes based on their p-adj value are shown in both groups
next to the green arrow and the top 4 downregulated genes value are shown in both groups next to the red arrows
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Discussion
Therapies utilising pluripotent stem cell derivatives are
an expanding market, with around 30 clinical trials cur-
rently ongoing [66]. Tenocytes derived from ESCs may
too prove a useful cellular therapeutic for promoting
scar-free tendon repair, like that observed in fetal ten-
dons. However, the difficulties associated with tenocyte
identification and a lack of direct comparative studies on
ESC-tenocytes makes it difficult to assess their potential.
Here we report for the first time the transcriptional pro-
filing of adult, fetal and ESC-tenocytes cultured in a 3D
environment and show that ESC-tenocytes are transcrip-
tomically closer to fetal as opposed to adult tenocytes.
We also demonstrate that culturing adult and fetal cells
in 3D results in a large divergence of their gene expres-
sion profiles in comparison to 2D static monolayer cul-
ture. This result indicates that 3D culture is a more
robust method to assess differences in the same cell
types from different developmental stages, which would
otherwise be lost in conventional culture systems. Col-
lectively, these results indicate that 3D-differentiated
ESC-tenocytes may be a useful cell source for the treat-
ment of tendon injuries in the future.
This data suggests that our differentiation protocol,
like others [42, 50, 67–70], mimics normal tenocyte de-
velopment. As previously described, the contraction
rates and survival of 3D adult, fetal and ESC constructs
showed no significant differences, with histological ana-
lysis showing similar cellular morphology and alignment
of the collagen fibres [50]. Collagen type I and type III,
which are the major components in tendon tissue, did
not significantly differ in gene expression and no qualita-
tive differences were determined histologically. Add-
itional quantification of the precise collagen content and
fibre alignments would be needed to confirm this. Al-
though there are many differences in gene expression
between ESC-derived, fetal and adult tenocytes (suggest-
ing all three groups represent unique populations), this
study shows that of the 26,991 genes mapped, ESC-
tenocytes have fewer DE genes when compared to fetal
tenocytes (2708 genes) as opposed to adult tenocytes
(2940 genes). Results similar to this have been described
in ESC-derived human neural stem cells, where 2041
genes were DE compared to fetal neural stem cells [71],
and ESC-derived human pancreatic β cells, where 755
genes were DE compared to adult pancreatic β cells [66].
One of the main challenges in assessing tendon differ-
entiation is the lack of definitive markers to identify ten-
don populations [72] and a panel of tendon-related
genes is usually used. Yet, many of these tendon-related
genes are widely expressed in various tissues [13, 72, 73].
Similarly, Zhang et al. highlighted the lack of available
micro-array and RNA-seq datasets documenting the
transition from fetal to adult tendon, with most datasets
only comprising of the initial stages of embryonic limb
development [72], therefore what stage of tendon devel-
opment differentiated progeny represent is not always
apparent. This study further highlights the issues in this
form of assessment. Of the 12 tendon-related genes
commonly investigated, four were found to be DE be-
tween adult and fetal tenocytes. Three of these genes
THBS4, SCX and MKX [74, 75] are some of the most
commonly cited “tendon” genes, and interestingly, all
show a clear gradient of expression, with adult tenocytes
having the highest expression, followed by the fetal and
then ESC-tenocytes. We also demonstrate that SCX and
THBS4 are rapidly downregulated in 2D culture and the
response of all three of these putative marker genes to
2D and 3D culture differs between adult and fetal cells.
They may therefore not be suitable as markers of a re-
generative cell type.
Our work does not address the heterogeneity of our
sample populations. Although we believe that 3D culture
is a potent driver of ESC differentiation into tenocytes,
quantification of the percentage of desired cell fate
achieved has not been conducted [50]. Yet even in very
optimised differentiation protocols in human ESCs, sig-
nificant variation in differentiation efficiencies is found,
with certain lines more readily differentiating down cer-
tain lineages than others due to epigenetic, cell cycle
patterns and genetic differences between lines [76–78].
To try and counteract this problem, cell sorting is typic-
ally performed [79]; however, this relies on a suitable
marker being available. Similarly, we have not measured
the heterogeneity within the tendon population itself.
Studies using single-cell RNA-seq suggest that different
sub-populations of tenocytes exist [80], with multiple
progenitor populations having been derived [81]; there-
fore, further study to identify sub-populations of cul-
tured tenocytes is required. The heterogeneous nature of
the ESC-tenocyte population is therefore likely, in part,
to explain why the musculoskeletal gene expression pro-
file is less robust in ESC-tenocytes compared to both
adult and fetal tenocytes.
Wound healing occurs firstly via an acute and local in-
flammatory response; this leads to cellular proliferation
and ECM deposition to remodel the injured tissue [82].
In adults, there is rapid cellular proliferation and a de-
layed but excessive accumulation of unorganised ECM
resulting in scar tissue. In contrast, fetal wounds regen-
erate with non-disrupted collagen ECM through simul-
taneous proliferation and synthesis of organised collagen
[83]. Although the exact mechanisms of fetal scar-less
healing are unknown, various studies suggest this regen-
erative ability is partly explained by intrinsic differences
between adult and fetal fibroblasts themselves. Compara-
tive studies have indicated that differences in the migra-
tory activity; inflammatory responses; cellular-mediated
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expression of chemokine, cytokines and growth factors;
and deposition of components of the ECM may play a
vital role [11, 83–85].
One of the top DE genes between adult and fetal teno-
cytes was LOXL4, a member of the lysyl oxidase gene
family which are responsible for initiating collagen and
elastin crosslinking in the ECM via signalling through
the TGF-β pathway [86]. LOXL4 has been heavily impli-
cated in fibrosis in skin and vascular tissue [87] and is
downregulated in Murphy Roth Large (MRL) mice
which heal without scarring [88]. Interestingly, this gene
is significantly downregulated in both fetal and ESC-
tenocytes (− 5.03 and − 9.68 logFC, respectively) com-
pared to adult tenocytes, a result which was confirmed
at both the mRNA and protein level. Other genes within
this top cluster that are downregulated in both fetal and
ESC-tenocytes, compared to adult tenocytes, include the
Integrin Subunit Beta Like 1 (ITGBL1) gene which can
promote chondrogenesis [89] and ANKH, an inorganic
pyrophosphate transport regulator, which has been
linked to calcification in articular cartilage. The rele-
vance of other genes within this cluster, WSCD2,
FRMD7 and PYCR1 are not yet clear. Heatmap clusters
2 and 3 contain genes that are significantly higher in
fetal tenocytes compared to both adult and ESC-
tenocytes and include ADGRL3, which play a role in cell
adhesion, and LURAP1L, which is involved in cell migra-
tion. FNDC3A is involved in extremity development and
fin regeneration [90], but its role in mammalian limb de-
velopment is still to be determined. Other genes in these
clusters have no clear role in tendon development.
Interestingly, the expression patterns of many chemo-
kines, cytokines and growth factors, involved in cell mi-
gration, were also found to differ between adult and fetal
tenocytes. As such, preliminary testing was conducted to
investigate the differences in adult and fetal cells’ migra-
tory response to growth factors. Of those tested, TGF-
β3, which is heavily involved in the wound repair
process [91–93], significantly inhibited fetal tenocyte mi-
gration, yet had no effect on adult tenocytes. This obser-
vation confirms previous reports in skin and oral
mucosa fibroblasts [85, 94, 95]. Interestingly, TGF-β3
has been implicated as a “critical traffic controller”
which can selectively halt the migration of certain cell
types during skin wound repair to ensure proper wound
closure [96]. Further investigations to underpin the po-
tential mechanism behind this differing response to
TGF-β3 and the effect of TGF-β3 on ESC-tenocytes are
warranted.
One limitation of our migration studies is that investi-
gations were conducted on conventional plastic substra-
tum. It has previously been reported that cytokine and
growth factor actions are substratum-dependant [95, 97,
98] which highlights the need to develop assay systems
which more closely resemble the in vivo environment.
Our results highlight this point, with only ten genes be-
ing found to be significantly different between the 2D-
cultured adult and fetal tenocytes, compared to the 542
genes which were DE in 3D culture. This supports previ-
ous studies showing that distinct gene expression pro-
files between cell types isolated from different stages
[99], and different tissues [23], are better preserved in
3D culture. What was more surprising was that adult
and fetal tenocytes appeared to modulate gene expres-
sion differently when exposed to a 3D culture environ-
ment, with very few DE genes overlapping when
comparing the two. Unfortunately, we were unable to
compare these results to the native tissue; therefore, fur-
ther research is necessary to confirm whether this
change in expression under 3D culture mimics that of
their true in vivo counterpart.
Conclusion
In summary, this study demonstrates that there are sig-
nificant differences in tenocyte populations cultured in
3D at different developmental stages. ESC-tenocytes
were transcriptomically closer to fetal than adult teno-
cytes. We were also able to add further evidence as to
the benefits of 3D culture as opposed to conventional
monolayer passaging. Future studies to optimise this 3D
model to allow study of the wound healing environment
in adult and fetal cells is likely to prove fruitful, and our
transcriptomic data may help to identify key modulators
involved in the scaring process as well as highlight if
ESC-tenocytes will indeed prove a useful therapeutic.
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S2. Primary and secondary antibodies used for immunocytochemistry.
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upregulated for each pairwise comparison of DE genes in adult, fetal and
ESC-tenocytes based on entity score. Table S4. GO analysis of DE genes
between adult and fetal tenocytes cultured in 2D versus 3D. Summary of
the significantly enriched gene ontology (GO) biological process terms.
The panther GO-slim statistical overrepresentation test tool was used to
determine over representation of defined GO classification for the 183
genes that were commonly DE between adult and fetal cells in 2D versus
3D culture. Table S5. Gene Analytics pathway analysis of DE genes in 2D
versus 3D cultured tenocytes. (A) The GeneAnalytics pathway analysis
tool used to determine the top pathways which are upregulated in
monolayer cultures of fetal and adult tenocytes compared to 3D fetal
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Additional file 2: Figure S1. Box and whisker plots of COL1A2, SCX,
THBS4 and TNMD expression over serial passaging. (A) COL1A2
expression at P0 is significantly higher than at P6 and P7. (B) SCX
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expression at P0 is significantly higher than at P4 through to P10.
However, after P4 there is no significant change in SCX expression with
further passage. (C) THBS4 expression at P0 is significantly higher than at
P1 through to P10. However, after P4 there is no significant change in
THBS4 expression with further passage. (D) TNMD expression at P0 is
significantly higher than at P1 through to P10. However, after P1 there is
no significant change in TNMD expression with further passage. Error bars
represent the st.dev of 3 biological adult tenocyte lines. Statistical
significance tested using linear regression analysis in R (v.3.5.2), with an
asterisk (*) denoting statistical significance using P0 as the intercept.
Figure S2. Additional Haematoxylin and Eosin (H&E) and Picro Sirius Red
Staining Images. Hematoxylin and Eosin (H&E) and Picro Sirius Red
staining of the remaining two biological lines of fetal, adult and ESC-
derived 3D constructs. All cell types show similar collagen fiber alignment
and collagen content within the constructs after 14 days of culture. Scale
bar for H&E = 0.5 mm. Scale bar for Picro Sirius Red = 250 μm. Under
light microscopy all collagen fibers are red following Picro Sirius Red
staining, under polarized microscopy collagen type I fibers have yellow-
orange birefringence and collagen type III fibers have green birefrin-
gence. Figure S3. Heatmap of top 100, 200 and 500 DE genes in adult
and fetal tenocytes. Differential gene expression analysis for top 100, 200
and 500 genes DE in adult and fetal tenocytes. Dendrograms are based
on Pearson correlation, with red and blue colours representing up and
down regulated genes respectively. Samples with intermediate expres-
sion are represented in yellow. Groups are visualized in columns, with the
coloured bar above the heatmap indicating the grouping variable. Genes
are represented in individual rows, with patterns of up and down regu-
lated genes being classified into clusters.
Additional file 3. Gene level summaries.
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